John T Curnutte
CIK 1574589 · EVP R&D · last filed 2025-06-09
John T Curnutte is an EVP R&D who has filed 41 SEC Form 4 insider transactions across 3 companies since 2014. The most recent filing, for PLRX, was dated Jun 9, 2025. Across all open-market trades the lifetime net is −$7.8M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
41
-$7.83M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PLRX | Director | — | $1.13 | — | $0 | 5 | 2025-06-09 |
| Orchard Therapeutics plc (ORTX) Delisted | Director | — | $16.70 | — | $0 | 5 | 2024-01-24 |
| PORTOLA PHARMACEUTICALS INC (PTLA) Delisted | EVP R&D | 102,559 | — | — | -$7.83M | 30 | 2019-05-21 |
Recent Filings
41 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-09 | PLRX | Grant (A) | — | $0 | EDGAR |
| 2024-06-17 | PLRX | Grant (A) | — | $0 | EDGAR |
| 2024-01-24 | Orchard Therapeutics plc (ORTX) Delisted | Disp (D) | — | $0 | EDGAR |
| 2023-06-16 | Orchard Therapeutics plc (ORTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-08 | PLRX | Grant (A) | — | $0 | EDGAR |
| 2022-06-21 | PLRX | Grant (A) | — | $0 | EDGAR |
| 2022-06-08 | Orchard Therapeutics plc (ORTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-30 | PLRX | Grant (A) | — | $0 | EDGAR |
| 2021-06-17 | Orchard Therapeutics plc (ORTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-19 | Orchard Therapeutics plc (ORTX) Delisted | Grant (A) | — | $0 | EDGAR |